Clinical Assessment of the BreathAlert Device in Monitoring Apneic Episodes
Recruiting
Observational Study
Apnea Infant
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 0 – 17
- Sex
- Any
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- William Marsh Rice University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A team of researchers at Rice University in partnership with clinicians at Queen Elizabeth Central Hospital created BreathAlert, a low cost battery-powered monitor that detects and corrects apnea. This study evaluates the ability of BreathAlert to detect respiration and apneic episodes in infants. Data from BreathAlert and vital signs monitors is collected. The performance of BreathAlert in respir…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants will be identified using the eligibility criteria stipulated below.
1. The patient is currently being treated at QECH in the neonatal or pediatric ward.
2. The patient is deemed to be at risk for apnea or in need of respiratory rate monitoring.
3. A BreathA…
Contacts